Canna Law Blog

FEBRUARY 19, 2020

The second track for psilocybin is the pharmaceutical model. On the pharmaceutical side, the FDA’s willingness to grant breakthrough therapy status to psychedelic drugs, as mentioned above, has put psilocybin approvals in an expeditious place. At some point, federal policy finally evolves and change becomes inevitable.

Decriminalization 133

Decriminalization Research and Development Therapy Pharmaceutical 133

Cannabis Law Report

NOVEMBER 23, 2021

Department of Veterans Affairs (VA) says that while current federal marijuana laws have prevented the department’s physicians from recommending medical cannabis to military veterans, officials are “looking at” the possibility of an internal policy change and have discussed it with the White House. And it was very profound,” McDonough said.

Policy 52

Policy Marijuana Pharmaceutical Treatment 52

Veriheal

JUNE 19, 2023

The psychedelic drugs here include LSD, MDMA, psilocybin, ketamine, and ayahuasca, which are in high demand for mental health treatment and other therapeutic reasons. There was a corresponding increase in the suicide rate, which increased the demand for psychedelic drugs for necessary treatment.” billion in the next six years.

Therapy 111

Therapy Treatment Patients Policy 111

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The bill would allow qualifying patients to access all the alternative treatment centers instead of having to designate just one. NH resident?

Legislation 249

Legislation Patients Decriminalization Access 249

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Here’s the press release. The Project on Psychedelics Law and Regulation (POPLAR).

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

JUNE 2, 2021

and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Epidiolex is a Schedule V controlled substance approved for the treatment of seizures. Idaho Office of Drug Policy: Cannabidiol (CBD): [link].

Law 103

Law Marijuana Oil Pharmaceutical 103

MJ Business Attorneys

JUNE 29, 2018

The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

FEBRUARY 8, 2019

Senator Ron Wyden introduced legislation in the Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference. A subcommittee of the U.S. A Georgia bill to reduce marijuana possession penalties was defeated in a senate committee this week.

Legislation 187

Legislation Decriminalization Patients Access 187

The Cannigma

NOVEMBER 2, 2021

Overall, 65% of the respondents said that they use cannabis in lieu of prescription pharmaceuticals. The survey was compiled by Amanda Reiman , PhD MSW, the California policy manager for the Drug Policy Alliance. In addition, they were also significantly more likely to report more use days per week.

Cannabis 134

Cannabis Policy Pharmaceutical Patients 134

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Info

OCTOBER 11, 2019

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Canna Law Blog

MARCH 7, 2019

Under the FDCA, a drug is defined as “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease” or “intended to affect the structure or any function of the body.” Yet, as of the date of this post, the FDA has only approved CBD as a pharmaceutical drug in the treatment of epilepsy ( Epidiolex ).

CBD 101

CBD Legalization Food Epilepsy 101

United Patients Group

FEBRUARY 7, 2023

Cannabis is an effective treatment for pain and inflammation Cannabis is a natural alternative to pharmaceutical drugs. Cannabinoids like CBD have been found to be effective treatments for inflammation, including stomach ulcers and irritable bowel syndrome (IBS). It’s found in cannabis, as well as oranges and lemons.

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

The Blunt Truth

APRIL 20, 2021

Although not immediately effective, New Mexico and Virginia employers should immediately assess the implications of the laws on their current policies and drug testing practices. Virginia went further by enacting the first law providing employment protections to individuals using cannabis oil. Virginia’s Cannabis Oil Law.

Recreational 77

Recreational Legalization Oil Extraction 77

MMJ Recs

JUNE 26, 2020

Dispensing pharmaceuticals. Nursing practice often involves dispensing pharmaceuticals and providing direct patient care services. Employers have different policies when it comes to medical marijuana and nursing practice. Maintaining, repairing, or operating heavy equipment, or manufacturing processes.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

Cannabis Law Report

FEBRUARY 5, 2020

The success of our pharmaceutical arm Eco Equity over the past 18 months shows there is appetite for investment in the industry. We want our investors to feel confident and we want our investors to see returns, as well as achieving our main aim of finding alternative and natural treatments for life-threatening illnesses.”.

Seed-To-Sale 59

Seed-To-Sale Pharmaceutical Medicine Cultivation 59

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. POPLAR will publish original law and policy research. CR: Can you describe the existing landscape of psychedelics research?

Law 81

Law Research and Development Therapy DEA 81

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Br J Oral Maxillofac Surg. 2022 Jun;60(5):e677-e690.

CBD 143

CBD Seed-To-Sale Food Access 143

Veriheal

SEPTEMBER 22, 2021

We’re encouraged that SB711 has been advanced by the Judiciary Committee,” said DeVaughn Ward , who serves as senior legislative counsel for the Marijuana Policy Project. The final stage would see the governor put his signature on North Carolina’s medical cannabis bill. Home cannabis cultivation, on the other hand, would be forbidden.

Legalization 124

Legalization Patients Cultivation Legislation 124

Cannabis Law Report

APRIL 21, 2022

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Advocacy 52

Advocacy Therapy Clinical Trials Treatment 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 21, 2022

Kabir Nath brings decades of experience in the health care industry to his new role, most recently serving as Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co.,

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Cannabis Law Report

JANUARY 16, 2020

The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body which advocates for European evidence-based policy to improve patient access to high-quality cannabis treatment, has announced the appointment of Professor Jones, CBE, FMedSci, as its new Chairman. Professor Jones.

Medicine 45

Medicine Research and Development Pharmaceutical Policy 45

Cannabis Law Report

AUGUST 16, 2021

But DCS refused to comply, stating that Ridgell had neglected the child by exposing him prenatally to cannabis that “was not the result of a medical treatment administered to the mother or the newborn infant by a health professional.”. My client was the only one who presented any science,” Gunnigle said.

Safety 116

Safety Patients Cannabis Law 116

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It should be noted that the CMA represents Canadian physicians, promoting, among other things, health policies, strategies, and access to quality health care.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

AUGUST 7, 2022

Psychedelic Alpha Policy Map. Psychedelic Alpha, an independent community in the psychedelics space, keeps track of psychedelic drug policy reform across the United States. In 2018, the FDA granted COMPASS Pathways BTD to develop psilocybin therapy for treatment-resistant depression.

Law 74

Law Research and Development Therapy Treatment 74

The Cannigma

MAY 9, 2021

Four times the energy as the pharmaceutical industry. pharmaceutical industry energy expenditure. ’ (Sonya Yruel/Drug Policy Alliance). The path forward: Smart policy and innovation. But there’s a price. Mills states that this national energy expenditure is more than four times the aggregate U.S.

Agriculture 145

Agriculture Cultivation Wellness and Beauty Consumption 145

Cannabis Law Report

JUNE 23, 2021

. “We are excited to be initiating our pilot program with Medicann in Jersey, which represents a unique, ‘ring-fenced’ environment for establishing potentially numerous studies on the efficacy of treatments using plant-based therapies. For additional information, please contact: Sofiya Kleshchuk. Client Relations. +1 1 917 210 0543.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 24, 2021

Policy Implications. More investment is needed for research into the harm that the non-medical use of cannabis poses to health and to better define the range of health conditions for which cannabis products may be an effective treatment. A rise in the non-medical use of pharmaceutical drugs has also been observed in the same period.

Research and Development 99

Research and Development Supply Chain Pharmaceutical Treatment 99

Veriheal

SEPTEMBER 7, 2022

law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. Those who can afford to sacrifice medical program benefits to consistently access medical cannabis treatment will be fine. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C.

Patients 98

Patients Programs Access Treatment 98

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. Knowledge, attitudes and policies regarding medical cannabis and cannabis-based drugs are changing. Cannabidiol-based treatment receives marketing approval from EMA.

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

Cannabis Chronicles

MARCH 4, 2019

Research shows there are high times ahead for all kinds of careers in cannabis , ranging from greenhouse and dispensary operators to edible product developers, marketing specialists, quality assurance lab directors and pharmaceutical researchers.

Education 100

Education Research and Development Hemp Programs 100

Cannabis Law Report

JULY 19, 2021

Philip Morris International recently offered £1 billion to buy Vectura Group PLC, the British pharmaceutical company that develops inhaled medical products. The global market for inhalation drug delivery devices is predicted to reach $17.6 billion by 2027. About RYAH Group, Inc. Client Relations. +1 1 917 210 0543.

Therapy 76

Therapy Data Research and Development Pharmaceutical 76

SpeedWeed

MARCH 13, 2021

Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. However, common treatments do not address the non-motor symptoms and can sometimes cause side effects including dyskinesia, an abnormality or impairment of voluntary movement. . View original article.

Patients 52

Patients Treatment Therapy Sleep 52

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

United Patients Group

FEBRUARY 2, 2023

The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e., antibiotics).

Blood Pressure 106

Blood Pressure Sleep Chronic Pain Digestion 106

Weedistry

DECEMBER 29, 2018

Two years ago, the people of Florida overwhelmingly voted to approve Amendment 2, creating a constitutional right for those with medical conditions to seek treatment through medical marijuana. Across the state, there are doctors — like me — who have started up clinics to help determine and facilitate treatment for those who need it most.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45